Losartan Potassium Tablets recalled over manufacturing violations
- Recall date
- March 1, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Legacy Pharmaceutical Packaging LLC recalls Losartan Potassium Tablets, USP, 50 mg, 30 tablet bottles, Rx Only, Distributed by: The Kroger Co, Cincinnati, OH 45202…
- Recall number
- D-1075-2019
- FDA classification
- Class II
- Brand / firm
- Legacy Pharmaceutical Packaging LLC
- Sold / distributed
- AZ, IN, TN
Why it was recalled
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Losartan Potassium Tablets, USP, 50 mg, 30 tablet bottles, Rx Only, Distributed by: The Kroger Co, Cincinnati, OH 45202, Manufactured for: Torrent Pharma Inc., 150 Allen Road, Suite 102, Basking Ridge, NJ 07920, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045 NDC 68645-494-54
Get recall alerts
Free email alert whenever Legacy Pharmaceutical Packaging LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Legacy Pharmaceutical Packaging LLC